Clinical trials recruiting for Breast Cancer Invasive
18
Recruiting trials
5
US states with sites
12
Countries
11%
Accept healthy volunteers
Phase breakdown
Phase 2 2Phase 3 1Not applicable 15
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALL-in-one radiotherapy | 1 |
| Azacitidine | 1 |
| IMRT | 1 |
| NabPE | 1 |
| Pyrotinib | 1 |
| Serplulimab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| New York | 1 |
Top cities
Atlanta, Georgia 1Chicago, Illinois 1Miami Beach, Florida 1New York, New York 1Sacramento, California 1
Self-screener
Recruiting trials
- A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery
- ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
- AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
- BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
- COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
- Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB)
- Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
- Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
- Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
- Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
- Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)
- GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
- Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery
- Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial
- NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
- Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)
- Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
- Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
Related conditions
Trials recruiting for Breast Cancer Invasive often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Prostate cancer 1234Pancreatic cancer 870Oligoprogressive 7Node Positive Breast Cancer 7Metastatic Cancer 31Lung cancer 2180Early-stage Breast Cancer 27Breast Neoplasms 105Breast Carcinoma in Situ 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Cancer Invasive trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.